induced calcium release from the sarcoplasmic reticulum, whereas the sustained inotropic effect during the subThe force and frequency of myocardial contraction are sequent beats results from both increased influx and physiologically regulated by neurotransmitters and horincreased mobilization of internal calcium resulting from mones. Norepinephrine released by the sympathetic nerves an increased replenishing of the reservoir of calcium in the in the heart and epinephrine released into the circulation by sarcoplasmic reticulum [2,3]. adrenal glands increase myocardial contractility by acting A hallmark of the b-adrenergic effect on the heart is to on both a-and b-adrenergic receptors on heart muscle. increase the rate of relaxation which has been related to Opposed to that is the action of acetylcholine released more rapid termination of calcium influx, increased rate of from parasympathetic nerves which reduces contractility calcium uptake and sequestration into the sarcoplasmic by binding to muscarinic cholinergic receptors. The first reticulum following phospholamban phosphorylation [4,5], demonstration that these two autonomic pathways are increased expulsion of intracellular calcium via sodium / regulated by nitric oxide (NO) produced endogenously calcium exchange [6], and dissociation of calcium from within cardiac muscle cells [1] both completes the troponin after the contraction [7,8]. understanding of the molecular mechanism of action of neurotransmitters in the heart and offers potential new 1.1.1. b-Adrenergic receptors therapeutic approaches for the correction of the altered Even though binding studies with selective ligands have responsiveness of cardiac muscle to autonomic regulation revealed two subtypes of b-adrenergic receptors in the in circumstances such as heart failure.
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heart (b-1 and b-2), the b-1 subtype usually predominates We will briefly review the molecular pathways leading in the mammalian heart. In the rat heart, the percentage of to the intracellular actions of b-adrenergic and muscarinic b-1 subtype is 85%. The ratio of b-1 and b-2 differs in cholinergic agonists in the cardiac myocyte, integrating the different regions of the human heart, where the percentage more recent evidence implicating the NO pathway from of b-1 is higher in ventricle than in atrium [9] . Recently, the single myocyte to clinical situations.
evidence was provided for the expression of b3 adrenoreceptors (at the mRNA level) in biopsy specimens from 1.1. b-Adrenergic pathway human ventricles. Functionally, activation of this receptor with specific agonists (in the presence of b1 and b2 b-Adrenergic agonists are well known to increase the blockade) produced a unique negatively inotropic effect on force and frequency of contraction and increase the rate of the contraction of human myocardium [10] . relaxation of cardiac muscle. Despite some differences between regions of the heart, in general, the early increase 1.1.2. Cyclic AMP intracellular pathway in force of contraction is related directly to an increase in b -adrenergic receptor stimulation increases cyclic regulatory proteins containing the a (or stimulatory) V for this cyclic nucleotide between the two isoforms, s m a x subtype. Adenylyl cyclase belongs to a family of enzymes and perhaps the localization of each isoform of PDE that convert ATP to cyclic AMP which in turn activates together with effector proteins for cAMP in the same several target molecules, primarily cyclic AMP-dependent subcellular compartment. protein kinases to regulate the activity of downstream proteins. Even though adenylyl cyclase isoforms are 1.2. Muscarinic cholinergic pathway widely distributed, only types V and VI have been definitively identified in ventricular heart tissue. Expression of Molecular cloning has allowed the identification of five the type VI isoform is most abundant in the fetus, gradually muscarinic receptor subtypes named m1-m5 based on the declines with age and reaches its lowest level in mature order of their discovery [14] . Even though the study of the adults. As all the other isoforms, these two types are also functional coupling of heterologously expressed receptors stimulated by Ga but are unaffected by calcium / calhas led to the general distinction between those isoforms s modulin as opposed to the other types [11] . that either mobilize intracellular calcium (m1, m3 and m5) Many isoforms of adenylyl cyclase, including type V and or inhibit adenylyl cyclase (m2 and m4), this classification VI are inhibited by G -linked receptors. In addition, type is somewhat arbitrary. There is ample evidence that m2 i VI adenylyl cyclase can be at least as effectively inhibited and m4 receptors also do stimulate phospholipase C by elevations in intracellular calcium, providing a mechathrough a pertussis toxin-sensitive G protein, thereby nism for the cross-talk between calcium-and cyclic AMPgenerating intracellular diacylglycerol (DAG) and IP3 dependent signaling pathways, both important regulators of through hydrolysis of membrane phospholipids, with subcardiac contractility.
sequent liberation of calcium from the endoplasmic reticulum [15] . In addition, G protein bg subunits were also 1.1.3. Cyclic AMP phosphodiesterases shown to couple m2 receptor stimulation to phospholipase As for other intracellular cyclic nucleotides, the levels of C b2 [16] . cyclic AMP are tightly regulated by a complex family of different phosphodiesterases widely distributed among 1.2.1. Intracellular effectors for the action of various tissues, including the heart. Among the different acetylcholine in the heart members of at least seven families, members of the PDE I, Most of the functional effects of acetylcholine in the II, and III were clearly shown to be expressed in heart heart have been attributed to the activation of three main tissue. PDE I is regulated by calcium / calmodulin and intracellular effectors: activation of potassium channels, therefore the regulation of the overall cyclic nucleotide inhibition of adenylyl cyclase, activation of soluble concentration by this isoform in a cell is expected to be guanylyl cyclase leading to increases in intracellular cyclic complex because of competition for the active calcium-GMP with subsequent activation of downstream cyclic calmodulin cofactor between the phosphodiesterase and GMP-dependent effectors. At the outset, one should bear other calcium calmodulin-binding proteins, such as protein in mind that even though the density of cholinergic phosphatases and constitutive nitric oxide synthases innervation differs among regions of the heart with the (NOSs). PDE II contains a non-catalytic binding site sinoatrial node and atrioventricular conducting systems having high specificity for cyclic GMP. When cyclic GMP being classically under the influence of dense parasympabinds to this site, it increases the affinity of the catalytic thetic innervation in mammalian hearts, recent work using site by allosteric interaction. PDE II is therefore known as viral tracing experiments also identified a rich distribution a cyclic GMP-stimulated phosphodiesterase. In general, of vagal innervation throughout ventricular cavities [17] . PDE II isoforms have been found to be expressed in
In the absence of b-adrenergic stimulation, however, the tissues in which the effect of cyclic GMP are opposite to effects of acetylcholine are small in ventricular tissue. those of cyclic AMP. The expression of an isoform of PDE When the heart is first stimulated by b-adrenergic agonists, II in heart myocytes from several species, including rat the effect of acetylcholine is greatly potentiated, a phenom-[12,13] is an illustration of this principle. By contrast, PDE enon previously termed 'accentuated antagonism' [18] . III isoforms are inhibited by cyclic GMP. In the heart, such inhibition by cyclic GMP would initially potentiate the 1.2.1.1. I The activation by acetylcholine of a K-Ach increase in intracellular cyclic AMP, thereby producing a unique species of potassium channels, designated as I K-Ach positive inotropic effect probably through an increase in mostly accounts for this phenomenon at the sinoatrial node L-type calcium current. The net result of cyclic GMP and atrium, even though this current is also affected by increases in heart muscle cells, however, is more difficult acetylcholine in the absence of catecholamine stimulation. to predict given the co-expression of both PDE II and PDE The anatomical distribution of this channel varies greatly III isoforms in the same myocytes at least in the rat species in the heart, with very little representation at the ventricu- [12] . Factors probably concurring to produce either a lar level. In addition the proportion between heart champotentiation or an attenuation of the cAMP effects in heart bers varies according to the species considered with a muscle cells include the relative differences in affinity and ventricular I density at about 25% that of the atrium K-Ach in the frog [19] . In other species, where the channel is present at very low levels in the ventricule, the action of acetylcholine must be accounted for by the activation of alternative pathways. 1.2.1.3. NO and cyclic GMP However, the observation of a dissociation between the functional effects of acetylcholine and cyclic AMP levels [22] [23] [24] prompted the search for other second messenger pathways linked to muscarinic receptor stimulation. These include activation of guanylyl cyclase to produce increases in intracellular cyclic GMP. Although a critical review of the early controversial evidence for the role of cyclic GMP as regulator of cardiac contractility is beyond our scope, more recent experiments using exogenous NO donors or cyclic GMP analogues have now established the importance of this cyclic nucleotide in the control of cardiac contractility.
As will be developed later on, most of the initial controversy may have stemmed from now well-recognized 2. NOS isoforms in heart muscle cardiac microvascular endothelial cells, cardiac myocytes, neurons, vascular smooth muscle cells, and infiltrating There is now ample evidence that all three isoforms of inflammatory cells (for a review, see [37] ). The relative NOS (nNOS, iNOS, and eNOS each encoded by a different abundance of iNOS expression within each cell type in gene, NOS1, NOS2 and NOS3, respectively) are expressed vivo may be substantially different from the results within various cell types in the myocardium. In human observed after exposure of cultured cells to recombinant hearts, eNOS expression has been demonstrated in endocytokines in vitro. Of note, some studies have emphasized thelial cells and cardiac myocytes from atrial and subenthe relative difficulty of inducing iNOS expression in docardial ventricular tissue, whereas iNOS immunostainhuman cells and the need to use a combination of multiple ing has been reported, albeit with some variability between cytokines, at least in vitro [45] . In addition, immunostudies, in cardiomyocytes, vascular smooth muscle and staining for iNOS in the myocardium is not only spatially endothelial cells and infiltrating macrophages (see below). heterogenous but also discontinuous over time, which may explain some of the discrepancy between published re-2.1. nNOS ports, especially in human tissue. Finally, the relative expression of iNOS in parenchymal cells versus infiltrating nNOS has been identified in both cholinergic and nonmonocytes varies significantly according to the etiology of adrenergic, non-cholinergic nerve terminals, in specialized the cardiomyopathy, e.g. between septic, transplant rejecconduction tissue and in sympathetic nerve terminals of the tion, ischemic or dilated cardiomyopathies. In human guinea pig heart [27, 28] , where it could be immunodilated cardiomyopathic hearts, iNOS protein has been histochemically co-localized with tyrosine hydroxylase colocalized with tumor necrosis factor (TNF), which along [29] . Cardiac myocytes, however, do not seem to express with other inflammatory mediators (i.e., IL1, IL6, IFN) the canonical nNOS, at least in the rat [26, 30] , or the was recognized as a component of the 'innate' immune muscle specific isoform of nNOS (nNOS-m; [31, 32] ). In response. The fact that the circulating levels of all these rabbit hearts, an NOS isoform with nNOS immunoreactiviinflammatory cytokines were found to be elevated in heart ty but slightly higher molecular weight (M 160 000) was failure raises the question of the role of iNOS expression r recently identified in SR vesicles [33] . as an adaptive or maladaptive immune response in heart failure and nevertheless highlights the multiple physiologi-2.2. eNOS cal roles of this isoform of NOS beside the regulation of autonomic stimulation of cardiac contraction. Endothelial cells from the endocardium and from arterial capillaries and veins express eNOS in a variety of species, including man [34] [35] [36] [37] . In addition, there is unequivocal 3. Regulation of the adrenergic pathway by nNOS evidence that eNOS is expressed in cardiomyocytes from atria, atrio-ventricular nodal and ventricular tissue in most Several lines of evidence indicate that NO produced mammalian species [26, 38, 39] and in man [35, 36, 40] . As endogenously by nerve terminals plays a role in the control in endothelial cells, palmitoylated and myristoylated eNOS of catecholamine release during electrical sympathetic in cardiac myocytes is localized to detergent-insoluble nerve stimulation. This was confirmed in isolated perfused glycosphingolipid-rich mycrodomains of the plasmalemma hearts [29] but also in vitro in PC-12 cells [46] and in called caveolae [41] . The presence of specific caveolinco-cultures between adult peripheral cardiac neurons and binding domains within eNOS allows direct protein protein cardiomyocytes [47] . In the latter experiments both exinteraction between the enzyme and the respective cellogenous NO release from SNAP and endogenous NO specific caveolin isoform, i.e. caveolin 3 in cardiomyocytes produced by co-cultured intrinsic cardiac neurons acted to and caveolin 1 in endothelial cells [42, 43] . Of interest, the increase the spontaneous beating frequency of co-cultured recent demonstration that caveolin 3 is expressed in the myocytes, whereas NO had no effect on monocultures of T-tubular system in cardiac muscle, which had been cardiomyocytes. These results are consistent with the suggested for years to develop from the coalescence of interpretation that NO either increases the release or clusters of caveolae at the sarcolemmal membrane [44] inhibits the reuptake of neuron-derived catecholamines at adds weight to the suggestion of a potential role of eNOS the pre-synaptic level. This interpretation was supported by in the regulation of excitation-contraction coupling in the independent experiments showing that S-nitrosothiols inheart. hibit neuronal norepinephrine transport [46] . The physiological role of nNOS was more directly 2.3. iNOS examined in vivo in homozygous mice deficient for NOS1 (nNOS2 / 2 mice). Under baseline conditions, nNOS2 / Virtually all cell types within the myocardium can 2 mice had a higher mean heart rate and lower heart rate express iNOS upon appropriate stimulation with specific variance than wild-type mice. Their chronotropic response combinations of inflammatory cytokines. These include to atropine was significantly blunted, suggesting a reduced baseline parasympathetic tone. However, the bradycardic effect of catecholamines on heart muscle, as reviewed response to a pressure challenge (phenylephrine injection below. Accordingly, we initially showed that inhibition of after b-adrenergic blockade) in nNOS2 / 2 mice was eNOS potentiates the positive inotropic response to isosimilar to that observed in wild-type controls. The reproterenol stimulation in isolated rat ventricular myocytes sponse to pressure challenge was strikingly more sensitive [25] . A similar observation was later reproduced in rat to PTX pre-treatment in nNOS2 / 2 mice compared to isolated atria [50] and atrial strips from non-failing human wild-type littermate, suggesting that the cardiac inhibitory hearts [51] . Furthermore, in rat atrial and ventricular cells G protein acts in parallel to neuronally-derived NO to as well as in human ventricular tissue, exposure to i mediate autonomic slowing of heart rate in the mouse [48] . isoproterenol induced an increase in intracellular cyclic GMP that was significantly reduced with NOS inhibitors [35, 50, 52] .
Modulation of the b-adrenergic response by eNOS
Several subsequent studies have since validated this paradigm in different animal preparations in vivo, where As for nNOS, the constitutively expressed eNOS is NO produced endogenously by a constitutive NOS in classically activated by calcium / calmodulin binding to its myocytes and / or neighbouring cells blunts the positive specific target sequence on each NOS monomer which inotropic effect of either infused catecholamines [53] , or enables electrons to flow from the enzyme reductase to the submaximal electrical stimulation of the left stellate ganoxygenase domain [49] . The EC50 for calcium activation glia in dogs [54] . In the latter study, intracoronary infusion of eNOS enzyme activity is 200-400 nM i.e. within the of the NOS inhibitor, L-NAME also significantly increased range of intracellular calcium concentrations observed after plasma norepinephrine concentration. The concept of the binding of agonists known to elevate intracellular eNOS-mediated attenuation of catecholamines' effect recalcium concentrations. Among these, b -adrenergic ceived further confirmation from experiments in mice 1 -2 agonists are well known to increase intracellular calcium homozygous deficient for eNOS (eNOS2 / 2) which exconcentration in cardiac myocytes through cyclic AMP and hibited an enhanced contractile responsiveness to positive PKA-dependent upregulation of calcium current through inotropic agents in comparison to wild-type controls. This voltage sensitive calcium channels (see above). In addition, finding, independently obtained by two different groups Gauthier et al. attributed the activation of eNOS in human [55, 56] was not confirmed in a two other studies using myocardium to adrenoceptors of the b3 family, for which isolated ventricular myocytes from these eNOS2 / 2 mice. they had previously identified specific mRNAs in extracts
The absence of potentiation of the effect of isoproterenol is of endomyocardial biopsies. Exposure of these ventricular explained by the use of maximal stimulating concenbiopsy fragments to norepinephrine in the presence of full trations of isoproterenol (1 mmol and above) in one [57] . a1-and b1-and b2-adrenoceptor blockade induced an
The presence of significant hypertrophy in the hearts from increase in the intracellular concentration of cyclic GMP the older (.3 months) eNOS 2 / 2 mice in the other that was abolished by inhibitors of NO synthase. These study invalidates the conclusions based on the comparison effects were reproduced with preferential b3-adrenoceptor with normal controls [58] . agonists, that also elicited increases in NO production
The activation by catecholamines of inverse inotropic directly measurable with a porphyrinic electrode [35] .
effects can be rationalized in terms of the concurrent activation of a family of adrenergic receptors coupled to 4.1. eNOS as a negative feedback for the b-adrenergic different intracellular pathways. This interpretation is inotropic effect supported by the demonstration of the coupling of b3-adrenoceptors to NOS activation in human ventricular The functional consequence of endogenous NO protissue with a resultant attenuation of contractile force duction by eNOS on cardiac contraction is complex, with strikingly contrasting with the classical b positive 1 -2 effects on peak contraction, duration of contraction and inotropic action of catecholamines (although this does not onset of relaxation, the direction and magnitude of which exclude the possibility of NOS activation by the other vary according to the preparation used and the species b-adrenoceptors) [35] . This paradigm somewhat recapituconsidered. In addition, some confusion has arisen when lates in the heart a similar co-activation of contracting and results obtained with endogenous NOS inhibitors were relaxing effects by catecholamines in the vasculature, directly compared with those of exogenous NO donor where the resulting tone is controlled by the balance drugs. Experiments with the latter have identified a potenbetween direct vasoconstriction of the smooth muscle and tiation or a down-regulation of the contractile response to endothelium-derived relaxing factors, including NO. In the b-adrenergic agonists in isolated hearts or cardiomyocytes, heart, the presence of both pathways (positively and NOdepending mainly on the concentration of NO applied. dependent negatively inotropic) within the same carMost studies evaluating the contractile effect of NO diomyocyte yields a similar negative feedback mechanism endogenously produced by eNOS do not identify an but in an autocrine fashion. Predictably, qualitative or enhancement but rather an attenuation of the inotropic quantitative alterations in either limb would alter the responsiveness to adrenergic stimulation and potentially time to half-relaxation was mainly the result of a marked contribute to the development of myocardial dysfunction, decrease in developed peak tension, without significant as reviewed below.
change in diastolic relaxation [35] . However, a recent study of the contractile performance of human transplanted 4.2. eNOS and arrhythmia hearts in vivo led to the observation that intracoronary administration of substance P reproduced the pattern of eNOS may also modulate other aspects of b-adrenergic earlier onset of relaxation with marginal decrease in peak stimulation of the heart. Aside from changes in inotropic systolic performance [63] , as previously identified in parameters, we recently observed that treatment of elecanimal papillary muscle or isolated ejecting hearts, as trically-paced human atrial strips with the NO synthase mentioned above. In addition the interplay between binhibitor, L-NMMA enhanced the arrhythmogenic effect of adrenergic stimulation and the paracrine effect of subsubmaximal concentrations (10 nM) of isoproterenol, as stance P was examined by monitoring systolic and diasmanifested by the occurrence of aftercontractions [51] .
tolic parameters in response to substance P infusion under Two additional independent pieces of evidence support a continuous infusion of dobutamine. Even though the role for NOS in controlling the threshold for adrenerresults were mainly interpreted as an accentuation of the gically-induced ventricular arrhythmia. In open chest dogs lusitropic effect of paracrine NO compared to that obtained with acute coronary artery occlusion, Fei et al. showed that with substance P alone, the study also showed a significant intrapericardial perfusion with L-arginine to increase NOS attenuation of the positive inotropic effect of dobutamine activity (as reflected by an increased NO effluent in the that recapitulates the paradigm of the counterregulatory coronary sinus) protected the myocardium against the effect of eNOS on the response to catecholamines as occurrence of ventricular fibrillation [59] . More recently, detailed in the previous sections. The mechanism underlythe role of myocyte-specific eNOS was directly assessed in ing the potentiation of the lusitropic effect of substance P the control of ouabain-induced arrhythmias, in which the in the context of pre-stimulation with a b-adrenergic occurrence of aftercontractions and I currents was comagonist remains elusive. It has been proposed to result ti pared between ventricular myocytes from eNOS2 / 2 from synergistic actions of NO-derived cyclic GMP and mice and from wild-type controls. The results showed that b-adrenergic-dependent activation of protein kinase A to ouabain induced more arrhythmic contractions and I desensitize contractile myofilaments to calcium. This interti currents in eNOS2 / 2 myocytes, and that these were pretation, however, is in contradiction with the previous efficiently prevented by the exogenous administration of demonstration, in isolated rat cardiomyocytes, that the S-nitrosoacetylcysteine, an NO donor [60] . These expericyclic GMP and protein kinase G-mediated desensitization ments clearly pointed to a role for myocyte eNOS in of cardiac myofilaments to calcium is abolished upon controling the arrhythmic threshold and may explain the concurrent stimulation with the b-adrenergic agonist, higher incidence of ventricular arrhythmias in circumisoproterenol [64] . stances where eNOS is downregulated. We previously showed such downregulation after intramyocardial eleva-4.4. Effects of exogenous NO donors on b-adrenergic tion of cyclic AMP with drugs such as milrinone [30] . The response notion that eNOS may be downregulated in the failing myocardium (see below) may further explain the arDespite important biochemical differences between NO rhythmogenic potential of inotropic drugs in patients with as generated from exogenous NO donor drugs or NO heart failure.
endogenously produced by NOS targeted to specific subcellular compartments, the use of nitrovasodilators or 4.3. Lusitropic effect of eNOS similar drugs has been valuable in understanding the potential intracellular mechanisms for the regulation by In the absence of pre-treatment with catecholamines, NO of cardiac function. As previously observed with the stimulation of endocardial endothelial cells of ferret papilregulation of L-type calcium current in isolated myocytes lary muscles with substance P was shown to produce a [65, 66] , exogenous NO donors or cyclic GMP analogs shortening of the duration of contraction by inducing exerted a biphasic effect on b-adrenergically-induced earlier onset of relaxation, with little effect on peak force positive inotropic effect depending on the concentration of of contraction [61] . Qualitatively similar results were later the NO donor and the resulting increase in intracellular obtained with bradykinin or substance P in isolated cyclic GMP. A potentiation of the effect of isoproterenol ejecting guinea pig hearts [62] . In ventricular biopsy was shown both in isolated ventricular myocytes and samples of human transplanted hearts which contain a papillary muscles from rats [67] and isolated feline papilmixture of endocardial, microvascular endothelial cells and lary muscles [68] . In the latter study, a biphasic effect on myocytes, activation of eNOS through b3-adrenoceptor baseline developed tension was observed with either 8-stimulation did not significantly alter the shape of elecbromo-cyclic GMP or treatment with Zaprinast, an inhibtrically-stimulated contractions, i.e. the shortening of the itor of phosphodiesterase type V that increases endogenous cyclic GMP levels. Low concentrations of NO donors (and Subsequent negative studies have emphasized that this resulting intracellular cGMP levels) increased developed coupling to NO production may not be operative in all tension whereas higher concentrations resulted in a negaanimals species or even in all regions of the heart tive inotropic effect. Interestingly, the transition from regardless of species differences. The pathway seems to be positive to negative inotropic effect was shifted to lower functionally absent in frog atrial myocytes [70] , ventricular concentrations of NO donors or Zaprinast when the myocytes from adult guinea pigs [71] , or in papillary muscles had been pre-stimulated with either muscarinic muscle from failing or non-failing human hearts [72] . In a cholinergic agonists or with the b-adrenergic agonist, recent study on the L-type calcium current of human atrial isoproterenol. Even though the precise mechanism of the myocytes which is sensitive to application of exogenous sensitization by previous b-adrenergic stimulation to the NO donors, Vandecasteele et al. found no effect of NO negative inotropic effect of cyclic GMP remained undesynthase inhibitors on the muscarinic cholinergic regulatermined from these experiments, it is tempting to specution of either baseline or adrenergically stimulated calcium late that it may be related to the activation by isoproterenol current [73] . As in most of these negative studies, howof an endogenous NOS to further increase endogenous ever, there was no assessment of NO production from cyclic GMP, as observed in rat ventricular myocytes [52] these preparations with an independent technique in the and human ventricular biopsies [35] . The concentrationparticular experimental conditions used. dependent shift from positively to negatively inotropic This and other limitations may also invalidate the effect of cyclic GMP elevation in the presence of bnegative conclusions from another recent study by the adrenergic stimulation may not be observed in all species same group [58] . Their contention that eNOS does not studied. For example, in a recent study on isolated ejecting mediate parasympathetic regulation of the heart is based on guinea-pig hearts, Prendergast et al. exclusively observed their observation that the responsiveness to muscarinic positive inotropic influences of either exogenous sodium cholinergic agonists in tissues from mice genetically nitroprusside or intracoronary substance P in the context of deficient for eNOS is unchanged from wild-type animals. b-adrenergic stimulation with dobutamine [69] . This posiForemost is the fact that their eNOS2 / 2 mice were not tive inotropic influence was manifested only by a change matched with the appropriate controls, i.e. (1) homozygous in the decay of the peak developed pressure in response to founder mice were not back-crossed into the appropriate long term infusion of dobutamine, with no change in peak strains to obtain homogenous genetic background between response to the catecholamine. Surprisingly, contrary to the eNOS2 / 2 and control eNOS1 / 1 mice, as is advisable previously mentioned observations in transplanted patients in such comparative studies; (2) eNOS2 / 2 mice were using similar protocols [63] , substance P had no significant studied between 3 and 6 months of age, when the chronic effect on the lusitropic effect of dobutamine, emphasizing hypertension characteristic of this genetic model had the need for caution when extrapolating functional results resulted in a significant myocardial hypertrophy, a phenoacross species.
type not independently accounted for in their comparison with normal controls [74] . In their multicellular (papillary 4.5. Mediation by eNOS of the 'accentuated antagonism' muscle or atrial) preparations, the persistence of the response to muscarinic cholinergic agonists in tissues from As mentioned above, the isoforms of muscarinic reeNOS2 / 2 mice may be explained by the activation of ceptors predominantly expressed on cardiomyocytes are I which is known to be present in atrial and ventricu-K-Ach mainly of the M2 subtype. M2 receptors mediate the lar cells [57] and can be upregulated in response to cyclase or G coupling to specific potassium currents intracellular and extracellular solutions in the experiments aq (I ). In addition, despite differences among mammalian with single ventricular myocytes. However, the latter were KAch species and regions of the heart there is substantial all performed at room temperature (19-238C) and the evidence for an indirect pathway mediating the muscarinic authors again do not provide independent evidence that cholinergic attenuation of adrenergic stimulation ('acceneNOS (in control myocytes) is active at such low temperatuated antagonism') through increases in cyclic GMP, as tures, thereby preventing any valid comparison. There are reviewed above. Since a main intracellular activator of the precedents for other misleading conclusions based on soluble isoform of guanylyl cyclase in many cell types is experiments performed at temperatures well below 378C NO, we first hypothesized that intracardiac increases in (for example see opposite conclusions regarding the funccyclic GMP were mediated through muscarinic cholinergic tionality of a cADPR pathway in cardiomyocytes in Refs. activation of endogenously expressed eNOS. This hypoth- [76, 77] ) and this is likely the case with such a sensitive esis was initially demonstrated by the abrogation of the enzymatic activity as eNOS in cardiac myocytes. chronotropic effect of muscarinic cholinergic agonists on By contrast, the involvement of eNOS in parasympaspontaneously beating neonatal rat myocytes by inhibitors thetic signaling was clearly demonstrated from the obof NOS [1] .
servation that the accentuated antagonism is completely lost in another study on isolated ventricular myocytes from of NOS did not affect the maximal rate response to vagal transgenic mice deficient for eNOS [57] . Importantly, the nerve stimulation in adrenergically pre-treated preparaloss of parasympathetic regulation of L-type calcium tions, but significantly slowed down the time course of the current in these myocytes was paralleled by the inability of vagal negative chronotopic effect. On the basis of the acetylcholine to increase intracellular cyclic GMP levels, subsequent observation of an acceleration of the rate whereas such increase was obtained in myocytes from response to vagal stimulation in the presence of inhibitors control animals (where it was also abrogated by NOS of the hyperpolarization-activated current, or I , which is f inhibitors under identical experimental conditions). Of known to be stimulated by NO [85] , they proposed that the note, eNOS2 / 2 mice in this study were appropriately modulatory role of endogenous NO on the vagal response back-crossed into C57 B / 6 and 129SvEv backgrounds, and may integrate both a potentiating effect, presumably studied at a younger age when they were exempt from mediated through inhibition of I , and an antagonistic Ca-L significant cardiac hypertrophy. Electrophysiological exeffect activating I , both of which are superimposed on the f periments were also performed at 32.58C. In a subsequent direct activation by acetylcholine of I , at least at the K-Ach series of experiments, Feron et al. were able to restore the atrial level. Moreover, these authors observed that applicamuscarinic cholinergic effect on both spontaneous beating tion of exogenous NO donors or 8-bromo-cyclic GMP rate and intracellular cyclic GMP increases by transfecting potentiated the chronotropic effect of vagal nerve stimulaneonatal myocytes from these eNOS-deficient mice with tion but not of directly applied acetylcholine, thereby plasmids encoding the wild-type (but not myristoylationimplicating an additional role of NO at the presynaptic deficient mutant) enzyme. Moreover, consistent with the level, a conclusion in agreement with previous results in paradigm of the mutually exclusive interaction of eNOS the anesthetized dog [82] . The existence of functionally with either activating calcium / calmodulin or inhibitory opposed effects of NO on the control of heart rate due to caveolin previously demonstrated in endothelial cells, interaction with multiple currents (i.e I , I but not
these authors showed that the eNOS-dependent muscarinic I ) in the atria probably explains the contradictory K-Ach cholinergic coupling was interrupted in these 'knock-in' results provided by different laboratories, depending on the experiments upon co-transfection of the ventricular preparation and protocol used (intact vagal nerve stimulamyocytes with plasmids encoding the myocyte-specific tion versus direct application of acetylcholine, presence or caveolin isoform, i.e. caveolin-3, or introduction into these absence of initial adrenergic stimulation), and the species myocytes of small peptides containing the sequence of the used (which may affect each current's relative contribution caveolin scaffolding domain involved in the specific to the control of heart rate). In the human species, we protein-protein interaction with eNOS resulting in the recently observed a partial abrogation of the accentuated inhibition of the enzyme [78] .
antagonism by NOS inhibitors in electrically-paced atrial Moreover, the paradigm of eNOS-mediated accentuated strips exposed to acetylcholine after submaximal stimulaantagonism has received confirmation from a number of in tion with isoproterenol [51] . vitro and in vivo experiments. In the rat species, eNOS
In this regard, the contribution of eNOS to the accenwas shown to be expressed in adult ventricular and tuated antagonism relative to other intracellular pathways atrioventricular myocytes, where it mediates acetylchocoupled to muscarinic cholinergic receptors may be more line's attenuation of adrenergically prestimulated contracidentifiable at the ventricular level, given the absence of tion and L-type calcium current [26, 38, 79] . Of interest, expression and / or significant functional role of I in f endogenous NO was also shown to mediate the indirect ventricular cells. As for other muscarinic cholinergic effects of adenosine on calcium current in rabbit heart responses, Gi / o proteins appear to be critical in the pacemaker cells [80] . In the anesthetized ferret adrencoupling of the NO-mediated accentuated antagonism. Preergically blocked with propranolol, NOS inhibitors sigtreatment of rats with pertussis toxin not only abolished the nificantly reduced the bradycardia induced by vagal stimumuscarinic cholinergic accentuated antagonism, which was lation, an effect that could be reversed by infusion of an shown to be NO-mediated but also controlled the abunexcess of L-arginine [81] . Similarly, in the anesthetized dance of eNOS proteins in the isolated hearts from the dog, infusion of L-NMMA into the sinus and atrioventricusame animals [86] . lar nodal arteries attenuated the negative chronotropic and dromotropic responses to vagal nerve stimulation in the absence or presence of adrenergic activation [82] . NOS 5. Modulation of the b-adrenergic response by iNOS inhibition, however, may not always affect the direct cholinergic actions of infused acetylcholine. In a series of There is extensive evidence for the expression of iNOS experiments in anesthetized rabbits and in isolated guinea protein in the multiple cell types comprising cardiac pig atria with preserved vagal innervation, Sears et al.
muscle, including in humans, in a variety of pathological outlined the existence of regulatory roles of exogenous or conditions such as sepsis, transplant rejection and in endogenous NO at various levels of cholinergic neurocertain cases, heart failure. In these circumstances, the transmission [83, 84] . In guinea pig isolated atria, inhibition physiological / pathological role of NO extends beyond the fine tuning of cardiac contractile response to autonomic reverse only part of the contractile dysfunction [98] or stimulation, as is the case for eNOS. NO produced by the showed a decreased cardiac function in the absence of 'high ouput' iNOS enzyme has been implicated in many iNOS induction [99] . Of interest, TNF, which was previaspects of cardiomyocyte biology such as immune defence ously shown to exert a minor role in the induction of iNOS against intracellular microorganisms, including viruses, in both microvascular endothelial cells and cardiac and apoptosis (for a review, see [37, 87] ). Although some myocytes in culture [92,100,101] also produced an attenuaor all of these phenomena may significantly bear on the tion of the b-adrenergic responsiveness in isolated contractile phenotype at the multicellular level, including myocytes in a NO-independent manner [96, 102, 103] . The of the heart in vivo, we will restrict our review on those latter effect may have involved a previously characterized effects of NO specifically produced by iNOS on the direct effect of TNF on the sphingomyelinase pathway to contractile responsiveness to b-adrenergic stimulation.
reduce cardiomyocyte contractile function [104] . This points to the multiplicity of signaling pathways leading to 5.1. iNOS and the b-adrenergic inotropic effect contractile dysfunction in response to inflammatory mediators in circumstances such as sepsis and may provide an In the early 1990s, experiments in neonatal cardiac explanation for the relative inefficiency of NO synthase myocytes had shown that cytokine treatment resulted in inhibitors or anti-TNF antibodies to reverse myocardial decreased contractile responsiveness to adrenergic agonists depression in some studies. Accordingly, in the human which was associated with an attenuation of the normal heart, despite the demonstration of increases in iNOS increase in intracellular cyclic AMP [88, 89] . Using specific proteins or activity in many disease states with myocardial combinations of recombinant cytokines or a mixture of dysfunction, as mentioned above, the use of NOS ininflammatory cytokines obtained from the culture superhibitors only variably restored contractile function (for a natants of rat macrophages stimulated with LPS, we found review, see [100] ). Although this would apparently argue that the reduced contractile response of isolated ventricular against a significant functional role for iNOS in the myocytes exposed to submaximal concentrations of isocontractile dysfunction, it should be emphasized that the proterenol was fully reversed upon co-treatment of the lack of effect of NOS inhibitors may have been explained cells with NOS inhibitors, thereby clearly implicating NO by the fact that they were administered at late stages of the production in the contractile dysfunction, at least under dysfunction when cardiomyocytes may have sustained these experimental conditions [90, 91] . Similar findings irreversible damage. Clearly, this does not rule out a role were subsequently observed using cultures of rat ventricufor iNOS in the early development of the contractile lar myocytes in co-culture with iNOS-expressing endodysfunction, probably in concert with many other inthelial cells [92] , as well as by many other groups using flammatory mediators (the action of which may also be either isolated contracting cardiomyocytes or papillary insensitive to NOS inhibition). muscles exposed to LPS alone or in combination with Likewise, the intracellular mechanisms responsible for other cytokines ( [93, 94] ; for a review, see [37] ).
NO-mediated attenuation of b-adrenergic responsiveness Among the inflammatory stimuli that result in iNOS are likely to be complex but may, in part, involve the same induction and myocardial depression, systemic infusion of mechanisms as those of NO endogenously produced by endotoxin has been widely studied in animal models eNOS, as will be reviewed below. because of its potential relevance to human sepsis. In a recent study in conscious mice, administration of endotoxin elevated the concentration of tumor necrosis factor (TNF) and interleukin-6 and resulted in the expression of 6. Intracellular mechanisms of action of NO in iNOS with subsequent elevation of circulating nitrite cardiac muscle cells within 4 h of injection. This was accompanied by a significant attenuation of the vasopressor effect of norad-
The effects of NO are classically distinguished between renaline that could be restored upon infusion of L-NMMA those dependent on cyclic GMP formation following the [95] . In neonatal rat cardiac myocytes in serum-free activation of guanylyl cyclase and those that are indepencultures, endotoxin similarly induced iNOS activity and dent of cyclic GMP. This classification however does not production of interleukin-6 and interleukin-1 that were all exclude the possibility that NO acts simultaneously abolished in the presence of dexamethasone. The expresthrough both mechanisms depending on the amount of NO sion of these inflammatory mediators blunted the b-adproduced, the intracellular versus extracellular source, renenoceptor-mediated increase in contraction amplitude, intracellular compartmentation of NOS and local redox whereas a-adrenoceptor responses where unaltered. The conditions, all of which are likely to impact on NO specificity of the effect of NO on b-but not a1-adrenergic reactivity with its intracellular targets. These restrictions actions had previously also been observed in other models aside, the use of exogenous NO donor drugs as well as [96, 97] . Other studies on myocardial depression accom-NOS inhibitors in isolated cells has greatly advanced the panying septic shock reported that NOS inhibition may understanding of the functional interaction between the NO synthase pathway and b-adrenergic signaling, which will attenuation of isoproterenol-stimulated increase in cyclic only be considered here (Fig. 1) .
AMP as well as the shortening of adult rat myocytes in culture [52, 90] . A similar mechanism may be operative for 6.1. Cyclic GMP-dependent mechanisms the attenuation of b-adrenergic responsiveness by NO produced endogenously by eNOS through its ability to 6.1.1. Enhancement of b-adrenergic response increase intracellular cyclic GMP following adrenergic Cardiomyocytes from most mammalian species express stimulation, as demonstrated in rat and human ventricular type 3 isoforms of phosphodiesterases or PDE3, which are tissue [35, 52] . The latter phenomenon could provide an allosterically inhibited by cyclic GMP. PDE3 was sugexplanation for the fact that NOS inhibitors only affect gested to mediate NO-induced increases in cyclic AMP myocyte contractile shortening when they have been preand the subsequent activation of L-type calcium current stimulated with b-adrenoceptor agonists [1,90]. and inotropy in isolated cardiac myocytes from rodents and In addition to activating PDE2, cyclic GMP can atalso human atria [66, 105] . Low concentrations of NO tenuate cardiomyocyte contraction by activating cyclic donors also induced a moderate positively inotropic effect GMP-dependent protein kinase (PKG). This protein may in adult rat ventricular myocytes [67] and in open chest in turn decrease the L-type calcium current stimulated by dog hearts [106] as mentioned above. In feline cardiac cyclic AMP-dependent PKA [113, 114] , or downregulate myocytes, the same pathway may mediate the rebound the contractile responses of myofilament proteins indepenincrease in L-type calcium current, calcium transient and dently of changes in calcium transients [64, 93, 115] at least contraction after the acute removal of acetylcholine in the absence of b-adrenergic pre-stimulation. Using the [107, 108] . Theoretically, intracellular cyclic AMP levels model of in vivo endotoxin treatment, Sulakhe et al. might also be regulated upstream from phosphodieseterstudied in parallel the contractile responses to isoprenaline ases, i.e. through direct regulation of adenylyl cyclase in isolated papillary strips and a variety of intracellular activity or its coupling to b-adrenoceptor through the target proteins in cardiomyocytes isolated from endotoxinstimulatory G-protein, a . Previous studies in lymphocytes injected rats. Attenuated contraction in response to isos have shown that NO can modulate the GTPase activity of prenaline in isolated muscles was paralleled by increased the small G protein, p21-Ras [109, 110] .
iNOS activity in the myocytes, while the phosphorylations NO-dependent increases in cyclic GMP may also potenof phospholamban and troponin-inhibitory subunit were tiate cardiac contraction through mechanisms independent decreased compared to extracts from control rats [116] . of cyclic AMP. Accordingly, Galione et al. provided These results would argue against an effect of iNOSevidence that intracellular cyclic GMP could activate derived NO on PKG-mediated phosphorylation of troponin calcium release from the ryanodine channel through activa-I to desensitize cardiac myofilaments to calcium [93] . tion of ADP ribosyl cyclase and subsequent increases in cyclic ADP ribose [111] . Recently, these authors demonstrated that the pathway may be operative to increase SR 6.2. Cyclic GMP-independent mechanisms calcium release in intact guinea pig cardiomyocytes [77] .
Accumulating evidence indicates that the oxidation of 6.1.2. Decrease in b-adrenergic response critical thiol residues on regulatory proteins by NO or On the other hand, cardiac myocytes from a variety of peroxynitrite may account for the effects of NO on various species also express the cyclic GMP-activated phosphoparameters of cardiac contraction. These effects are more diesterase, or PDE2. A rat isoform of PDE2 was recently likely to be produced with high concentrations of NO and identified as a main cyclic nucleotide phosphodiesterase superoxide anions in the context of inflammatory cytokine isoform in sino-atrial node cells from rabbits [112] , where stimulation leading to both the induction of the high-output the muscarinic cholinergic 'accentuated antagonism' on iNOS and oxidative stress. Among the contractile regula-L-type calcium current was also completely abolished by a tory proteins sensitive to oxidation, the cardiac calcium specific PDE2 inhibitor, EHNA. A similar pathway was release channel (ryanodine receptor) and the L-type calfound to be operative in atrio-ventricular and ventricular cium channel were shown to be regulated in a bimodal myocytes from rabbits and rats [26, 38, 112] .
way upon progressive poly-S-nitrosylation [117] [118] [119] [120] . NO, Combined with the notion that cardiomyocytes may and / or peroxynitrite may also potentially regulate key express both PDE2 and PDE3, the coexistence of these enzymes regulating oxygen consumption and ATP generafunctionally opposed pathways provides a explanation for tion within heart muscle, including creatine kinase and the bi-directional effect of NO or cyclic GMP in response cytochrome C oxidase (for reviews see [37, 121] ). These to b-adrenergic stimulation of L-type calcium current and observations emphasize the need to integrate the various contraction [65, 67] , as mentioned above. In circumstances bi-directional effects of NO on excitation-contraction where high levels of intracellular cyclic GMP are procoupling and the need to systematically verify that any duced, such as those generated upon NO production by effect produced with pharmacological concentrations of iNOS, the resultant activation of PDE2 leads to an NO donors is representative of the action of NO as produced by each specific NOS isoform targeted to subvalidate other studies on cardiomyocytes isolated form cellular compartments.
animal models of heart failure [127] . Finally, the ability of exogenous NO donors to produce quantitatively and qualitatively similar effects in isolated atrial and ventricu-7. NO-dependent attenuation of b-adrenergic lar strips from human failing and non-failing hearts adds pathway in heart failure further evidence for a significant role of NO as a modulator of b-adrenergic responsiveness [128] . Numerous studies have examined the involvement of either eNOS or iNOS in the depressed myocardial responsiveness to catecholamines in heart dysfunction from References different etiologies, including sepsis, transplant rejection, ischemic or dilated cardiomyopathies. myocytes from failing heart compared to those from non- 
